Fotuhi SN et al. found that BACE1-AS-lncRNA level in plasma and plasma-derived exosomes are significantly different between the AD subgroup and the control group, showing the possibilities of one of the biomarkers for AD [107]. This evidence concerns the gene BACE1 and Alzheimer disease.